Overview
First FDA-authorized autonomous AI for diabetic retinopathy detection.
Details
LumineticsCore (IDx-DR) is FDA De Novo authorized for autonomous diabetic retinopathy detection in primary care without specialist review.
First FDA-authorized autonomous AI for diabetic retinopathy detection. LumineticsCore (IDx-DR) is FDA De Novo authorized for autonomous diabetic retinopathy detection in primary care without specialist review.
First FDA-authorized autonomous AI for diabetic retinopathy detection.
LumineticsCore (IDx-DR) is FDA De Novo authorized for autonomous diabetic retinopathy detection in primary care without specialist review.
Turn AI reports into shareable sites
Publish reports & dashboards as websites
Make AI-generated reports public, stable, and easy to update — free to start.
Try Revdoku →